Previous close | 2.1300 |
Open | 2.1000 |
Bid | 2.0400 x 100 |
Ask | 2.2200 x 100 |
Day's range | 2.0350 - 2.1999 |
52-week range | 1.5500 - 5.4100 |
Volume | |
Avg. volume | 81,501 |
Market cap | 18.682M |
Beta (5Y monthly) | 0.76 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Data from a preclinical study shows that treatment with Alterity's (ATHE) lead candidate improved motor performance and general function in monkeys with experimentally-induced Parkinson's disease.
Key Insights Alterity Therapeutics' Annual General Meeting to take place on 28th of November CEO David Stamler's total...